Covidien Limited, which is chartered in Hamilton, Bermuda, has reported that its board voted to move its incorporation to Ireland next year, as part of a reorganization that will create an Irish holding company, Covidien plc.

Pie Medical Imaging (PMI) of Maastricht, Netherlands, has released its CAAS MR Flow analysis, which is currently an investigational device in the United States, as it is pending FDA approval.

Volcano, a developer and marketer of products for the diagnosis and treatment of coronary and peripheral artery disease, has entered into a definitive agreement to acquire Axsun Technologies, a privately held developer and manufacturer of lasers and optical engines used in optical coherence tomography (OCT) imaging systems.

The so-called triple rule-outa single cardiac CT angiography (CTA) exam to evaluate for coronary artery disease, pulmonary embolism (PE) and aortic dissectionhas not had an easy road to mainstream acceptance. And for good reason. It tends to increase radiation exposure, compared to a coronary CTA study, and the majority of studies are negative for PE and dissection.

Three studies have found that the triple rule-out exam is advantageous in certain patient populations and the senior author told Cardiovascular Business News that the postprocessing involved is simple and straightforward.

In MR angiography (MRA) of peripheral arteries, injecting contrast medium at a slow, balanced rate can alleviate contamination of veins in the calves while maintaining image quality, according to at multinational team of researchers from China and the United States.

The Certification Board of Cardiovascular Computed Tomography (CBCCT) earlier this month announced that 715 out of 878 examinees passed its first certification exam in cardiovascular CT.

The Society of Cardiovascular Computed Tomography (SCCT) hosted a one-day conference on Dec. 4 to review with private and public healthcare payors current evidence to support appropriate use of cardiovascular CT angiography (CCTA).